ArticleHeliyon2025
Eco-friendly extension of postharvest longevity in Alstroemeria cut flowers using melatonin and putrescine treatments.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Interactive effects of silica nanoparticles and putrescine on morphophysiological and biochemical performance in stock (Matthiola incana L. 'Pilaster White').Die Naturwissenschaften · 2026Article
- Melatonin pulse treatment optimization: boosting vase life and postharvest quality in cut roses (Rosa hybrida cv. Samurai).BMC plant biology · 2026Article
- Melatonin enhances nitric oxide, salicylic acid, and lignin accumulation to reduce neck bending and extend vase life of gerbera cut flowers.BMC plant biology · 2026Article
- Phytomelatonin in Ornamental Horticulture: A Comprehensive Review of Growth Promotion, Stress Tolerance, and Post-Harvest Quality.International journal of molecular sciences · 2026Review
- Integrated application of phosphite, phosphate, and arbuscular mycorrhizal fungi enhances postharvest longevity and quality of cut rose (Rosa hybrida cv. Dolce Vita) in soilless culture.BMC plant biology · 2025Article
- Integrative effects of melatonin and putrescine on vase life and physiological traits in cut alstroemeria 'Amatista'.BMC plant biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postharvest longevity is the most important factor concerning the commercial value of cut flowers. Alstroemeria 'Amatista' is one of the most valued species for its ornamental appeal and it has been often reported to suffer from premature senescence. The present study was undertaken to establish the efficacy of melatonin (100 and 200 μM) and putrescine (1.5 and 3 mM) as enviro-friendly compounds applied into the vase solution in extending the vase life of cut flowers of Alstroemeria by assessing different physiological parameters. Results showed that melatonin at 100 and 200 μM and putrescine at 1.5 mM significantly extended the flower vase life from 12 to 13 days (control) to 20-21 days. More precisely, both melatonin and putrescine lowered electrolyte leakage (EL) and increased relative water content (RWC), relative fresh weight (RFW), and relative solution uptake (RSU) of flowers. In addition, both compounds enhanced the total anthocyanin content, phenylalanine ammonia-lyase (PAL) and polyphenol oxidase (PPO) activities, and reduced malondialdehyde (MDA) and hydrogen peroxide (H₂O₂) content, which implies the decline in oxidative stress. These results confirm that both melatonin and putrescine act as effective and environmental-friendly exogenous applications to improve postharvest quality and extend the vase life of Alstroemeria cut flowers. The study provides important information for possible applications in the floriculture industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.